Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | PGK1 | P00558 | 1/20 | 0.45 |
| ▸ | PGK2 | P07205 | 1/20 | 0.45 |
| ▸ | PGD | P52209 | 3/20 | 0.42 |
| ▸ | MPI | P34949 | 1/20 | 0.42 |
| ▸ | LPAR5 | Q9H1C0 | 2/20 | 0.39 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.38 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.36 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.36 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.36 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1447095 | 0.98 | TDP1 (0.46) | TDP1PGK1PGK2PGDMPI | |
| SCHEMBL1628016 | 0.98 | TDP1 (0.46) | TDP1PGK1PGK2PGDMPI | |
| SCHEMBL8381650 | 0.85 | TDP1 (0.48) | TDP1 | |
| SCHEMBL7091562 | 0.85 | TDP1 (0.42) | TDP1LPAR1LPAR3 | |
| SCHEMBL3344507 | 0.84 | — | — | |
| SCHEMBL3340733 | 0.84 | — | — | |
| SCHEMBL1079057 | 0.84 | — | — | |
| SCHEMBL5179369 | 0.82 | TDP1 (0.40) | TDP1LPAR1LPAR3 | |
| SCHEMBL28767134 | 0.81 | TDP1 (0.42) | TDP1PGK1PGK2PGDMPI | |
| Phosphoric Acid SCHEMBL1447098 | 0.78 | TDP1 (0.46) | TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 298 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109776780-B | Phosphorus-containing flame-retardant PTT and preparation method and application thereof | 中国石油化工股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| CN-122070120-A | Oral care compositions | 巴斯夫欧洲公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-122005326-A | Oral care composition comprising gel network and potassium nitrate | 宝洁公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20250213456-A1 | ORAL CARE COMPOSITION COMPRISING A PEROXIDE AND AN ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK COPOLYMER | BASF SE (DE) | 2025-07-03 | — | — | US | disclosed |
| CN-119546271-A | Oral care compositions comprising peroxide and ethylene oxide/propylene oxide block copolymers | 巴斯夫欧洲公司 | 2025-02-28 | — | — | CN | disclosed |
| US-12233139-B2 | Oral care compositions containing a gel network phase | THE PROCTER & GAMBLE COMPANY (US) | 2025-02-25 | — | — | US | disclosed |
| CN-117643556-A | Oral care compositions containing gel network phase | 宝洁公司 | 2024-03-05 | — | — | CN | disclosed |
| WO-2024015246-A1 | ORAL CARE COMPOSITION COMPRISING A PEROXIDE AND AN ETHYLENE OXIDE/PROPYLENE OXIDE BLOCK COPOLYMER | BASF SE (DE) | 2024-01-18 | — | — | WO | disclosed |
| CN-109069361-B | Oral care compositions comprising gel network phase and potassium nitrate | 宝洁公司 | 2023-04-28 | — | — | CN | disclosed |
| EP-2346475-B2 | PERSONAL CARE COMPOSITIONS PROVIDING ENHANCED COOLING SENSATION | PROCTER & GAMBLE (US) | 2023-04-19 | — | — | EP | disclosed |
| WO-2010019730-A1 | SYNTHESIS OF CYCLOHEXANE DERIVATIVES USEFUL AS SENSATES IN CONSUMER PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010019729-A1 | SOLUTION OF MENTHANE CARBOXAMIDES FOR USE IN CONSUMER PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2010-02-18 | — | — | WO | disclosed |
| WO-2010004361-A2 | COMPOSITIONS AND METHODS FOR IMPROVING OVERALL TOOTH HEALTH AND APPEARANCE | THE PROCTER & GAMBLE COMPANY (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009134657-A1 | ORAL CARE COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2009-11-05 | — | — | WO | disclosed |
| US-20090269287-A1 | Oral Care Compositions | THE PROCTER & GAMBLE COMPANY | 2009-10-29 | — | — | US | disclosed |
| US-20080247973-A1 | Compositions and Methods for Improving Overall Tooth Health and Appearance | THE PROCTER & GAMBLE COMPANY | 2008-10-09 | — | — | US | disclosed |
| US-4654375-A | POLYOL AND SOLUBILIZED CARBOHYDRATE SOLUTION AND SECOND SOLUTION OF POLYISOCYANATE | SEALED AIR CORPORATION (US) | 1987-03-31 | — | — | US | disclosed |
| US-4142030-A | POLYURETHANE-SILICATE | BAYER AKTIENGESELLSCHAFT (DE) | 1979-02-27 | — | — | US | disclosed |
| US-4086193-A | POLYURETHANE COAGULATED | BAYER AKTIENGESELLSCHAFT (DT) | 1978-04-25 | — | — | US | disclosed |
| US-4042536-A | POLYISOCYANATE, SILICIC ACID, XEROGEL | BAYER AKTIENGESELLSCHAFT (DT) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12233139-B2 | Oral care compositions containing a gel network phase | FLNA, FLNB, FRG1 | TDP1 1944/4885PGK1 2075/4885PGK2 1856/4885 |
| US-20080247973-A1 | Compositions and Methods for Improving Overall Tooth Health and Appearance | ALPP, CHERP, CA3 | TDP1 337/4885PGK1 4023/4885PGK2 4103/4885 |
| US-20090269287-A1 | Oral Care Compositions | DSC1, GALC, TAS2R39 | TDP1 1071/4885PGK1 666/4885PGK2 1016/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.